A. Kis et al., Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase, BR J PHARM, 127(7), 1999, pp. 1545-1550
1 Cardiac pacing, in anaesthetized dogs, protects against ischaemia and rep
erfusion-induced ventricular arrhythmias when this is initiated 24 h after
the pacing stimulus. Now we have examined whether this delayed cardioprotec
tion afforded by cardiac pacing is mediated through nitric oxide.
2 Twenty-two dogs were paced (4x5 min periods at 220 beats min(-1)) by way
of the right ventricle, 24 h prior to a 25 min period of coronary artery oc
clusion. Nine of these dogs were given the inhibitor of induced nitric oxid
e synthase, aminoguanidine (50 mg kg(-1) i.v.), 0.5 h prior to coronary art
ery occlusion. Sham-operated non-paced dogs with and without aminoguanidine
treatment served as controls.
3 Pacing markedly (P<0.05) reduced arrhythmia severity (ventricular fibrill
ation, VF, during occlusion 15%; survival from the combined ischaemia-reper
fusion insult 62%) compared to control, sham-operated, unpaced dogs (VF dur
ing occlusion 58%; survival 17%). This protection was attenuated by the adm
inistration of aminoguanidine prior to coronary artery occlusion (survival
from the combined ischaemia-reperfusion insult 11%, which was significantly
(P<0.05) less than in the paced dogs not given aminoguanidine and similar
to the controls). Aminoguanidine had no significant effects on coronary art
ery occlusion when given to dogs that had not been paced. In the dose used
aminoguanadine transiently elevated systemic arterial pressure by a mean of
20 mmHg and reduced heart rate by a mean of 22 beats min(-1).
4 These results suggest that nitric oxide, probably derived from induced ni
tric oxide synthase, contributes significantly to the delayed cardioprotect
ion afforded by cardiac pacing.